Stryker to Acquire Amplitude Vascular Systems to Expand Peripheral Vascular Portfolio with Next-Gen IVL Technology

Stryker is a global leading medical device giant with businesses covering orthopedics, neurointervention, vascular intervention, emergency care, and more. Previously, in 2025, it acquired Inari Medical for $4.9 billion, further strengthening its position in the vascular intervention sector.

AVS, on the other hand, is an innovative company focused on vascular interventional technology, with a core focus on the next generation of endovascular treatment technologies.

The core of this acquisition is AVS's next-generation intravascular lithotripsy (IVL) technology, which mainlyTargeting Calcified Lesions in Peripheral Artery Disease (PAD)—— By using sound waves to break up calcified plaques within blood vessels without damaging normal vascular tissue, it solves the calcification challenges that are difficult to address with traditional surgery.

According to industry analysts, this technology is the new generation in the IVL field, with the potential to become a core competitor to Shockwave Medical and fill Stryker's technical gap in the peripheral intervention sector.